Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
about
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s DiseasePresentation and management of psychosis in Parkinson's disease and dementia with Lewy bodiesPsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Clinical correlates of depressive symptoms in familial Parkinson's disease.Depression in Parkinson's disease -- a review.Management of Parkinson's disease. Strategies, pitfalls, and future directions.A review of pramipexole and its clinical utility in Parkinson's disease.Psychiatric aspects of Parkinson's disease.Pathophysiology and treatment of psychosis in Parkinson's disease: a review.A systematic review of prevalence studies of depression in Parkinson's disease.The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.The organization of narrative discourse in Lewy body spectrum disorder.Prevalence of psychotic symptoms in a community-based Parkinson disease sampleA review of dual-task walking deficits in people with Parkinson's disease: motor and cognitive contributions, mechanisms, and clinical implications.Pharmacologic management of psychosis in the elderly: a critical review.Nonpharmacologic interventions for psychotic symptoms in dementia.Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.Stress, depression and Parkinson's disease.Impairments of speech fluency in Lewy body spectrum disorderPsychosis in Parkinson's disease.The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease.New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.Cognitive and behavioural impairment in Parkinson's disease.Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.Use of antipsychotic medications in patients with Parkinson's disease at Auckland City Hospital.An economic model of Parkinson's disease: implications for slowing progression in the United States.Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.Prevalence of depression in Parkinson's disease in a Lebanese tertiary clinic.Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E ε4 allele in a sample of Bulgarian patients with late-onset Parkinson's disease.Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.Dementia and functional decline in patients with Parkinson's disease.Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.Features associated with the development of hallucinations in Parkinson's disease.Dimensions of executive function in Parkinson's disease.
P2860
Q24188194-8A096F57-2D24-4080-B743-344A8037494FQ24680260-BA33B304-D5F7-46A4-ACE7-5510612F5BC7Q30249553-C8A0DF1D-8996-43F8-9407-77F17E701F07Q33861294-E7E6C518-C1C1-4FCC-B6ED-4F64BE6FB9AEQ34478301-FEDC530D-AC81-4347-B9C7-83A68445EC3EQ34490418-7CAA4FB6-8467-4E10-A342-97128E1DE571Q34519277-11F53192-3041-4EB0-B83B-42B5E9A03CABQ34574771-8E7DFF93-4ABC-486F-99ED-E9FB825BB3CCQ34610608-2632521D-BBA3-4F8A-A86C-8016399105ABQ34711370-8F685CFA-6BBF-48B6-81CD-69C5410B1587Q35098556-943BE4B2-AA4E-4777-A730-447A426F1B3FQ35184421-D6F29BD1-7312-4B50-BF8D-2D17763B6275Q35201060-77175E21-407F-4E46-BD87-4A81160E20FEQ35495735-5D567A84-DDB5-46DB-9717-993EAA2A8BD2Q35599469-4E3E80EF-4003-4DC0-A564-5D5ABD0E3468Q35599472-C2906282-12B5-43D8-8895-1D008EC661E4Q35661275-0DF1B06C-BD24-4C4F-B947-2C65A0B43081Q35713356-4E055F7A-AD80-4A8C-9DEF-1545EA8BBB6FQ35823236-0655EF67-4CB3-412C-93E7-F2FB907596BCQ35863404-C4F87077-B51C-4CB3-B55E-B3273AB074D3Q35947146-29DDED18-5652-4060-8161-84310483F798Q35988441-6AC5D7B5-FE42-478D-892A-07B93A14E7BAQ36011226-CF2A573C-807D-4290-8283-BCF6A0EDA2F0Q37016310-435E8B4F-493F-43D4-86D0-D26895C1747EQ37021326-40B765DC-0E62-417F-88C5-38FC428C64FCQ37299906-73E463FE-9AC1-4D4B-BAE6-4A5068FC31A0Q37689582-532CF0C9-4677-416C-AE6E-6E9DC6319205Q37862378-DA4E140A-92B0-4A8D-9512-4DB0576C4460Q38081100-F8FAF8EA-B9D3-4540-82D2-CE48A2FAA29BQ39004255-02DF88B1-5E32-474E-A68E-88D6FD0D4600Q41110293-F09DBBB6-2D63-4911-BDF7-AFD4DEB6AB4BQ43926955-72CAF27D-8A59-4A6F-A9F0-03ECAEC69251Q44390438-E0E911DA-60D4-4BA8-B6A2-0FFFEDD9C16DQ44654922-7D774FBD-5399-43D5-8DEC-69B109D0BBCCQ46352438-111E8E53-8F62-472B-86F8-0D40AD927B95Q46560199-826C0084-63BE-493F-9B7D-1ABBD92698BCQ47106246-50974FCD-8812-4455-9636-BC0CF53E8483Q47872914-99A717F4-D46E-4736-9E79-DA161DDB8017Q48433557-1FAEE3C6-67E3-4CA6-A7DD-C4954B621AE7Q48481633-6F71CD22-0EF5-483C-BE43-5BFAC4FA9159
P2860
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@ast
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@en
type
label
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@ast
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@en
prefLabel
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@ast
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@en
P2093
P921
P356
P1476
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
@en
P2093
B Kandinov
T A Treves
P2888
P356
10.1007/S007020050005
P577
2000-01-01T00:00:00Z